Wednesday Jan 18 | Science Daily
Continuing uncertainties surround anti-influenza drug
However, after piecing together information from over 16,000 pages of clinical trial data and documents used in the process of licensing oseltamivir by national authorities, a team of researchers has raised critical questions about how well the drug works and about its reported safety profile.
Tamiflu side-effects still unclear
Researchers combed through more than 16,000 pages of clinical trial data and documents used by regulators to approve oseltamivir, sold as Tamiflu.
Common winter illnesses can have similar symptoms. And one illness can easily lead to another one as the body struggles to fight off the first one.
The Department of Health announced yesterday it was upgrading influenza prevention measures by expanding government distributions of antiviral medications, after the flu virus claimed three more lives last week.
Also on Topix